VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
50 hedge funds and large institutions have $92M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
16% more call options, than puts
Call options by funds: $925K | Put options by funds: $800K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
50
Holding in Top 10
1
Calls
$925K
Puts
$800K
Top Buyers
| 1 | +$27.1M | |
| 2 | +$15.8M | |
| 3 | +$8.66M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$6.75M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.74M |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$347K | |
| 3 | -$182K | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$154K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$106K |